Please complete the CAPTCHA to continue
@sarcode.com
✓
11 phones found area 650, 415, 619, and 858
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Charles Semba (仙波), Md is listed as Chief Medical Officer and Board Member. Developing global innovative therapeutics for dermal aesthetics and vision-threatening diseases. Look better. See better. at Eluminex Biosciences Limited, based in South San Francisco, California, United States. AeroLeads shows a work email signal at sarcode.com, phone signal with area code 650, 415, 619, 858, and a matched LinkedIn profile for Charles Semba (仙波), Md.
Charles Semba (仙波), Md previously worked as Chief Medical Officer at Eluminex Biosciences Limited and Board Member at Diamedica Therapeutics Inc.. Charles Semba (仙波), Md holds Diagnostic Radiology from Uc San Diego.
This section adds company-level context without repeating Charles Semba (仙波), Md's masked contact details.
AeroLeads found 1 current-domain work email signal for Charles Semba (仙波), Md. Compare company email patterns before reaching out.
+20 years in therapeutic product development in public (Genentech, Shire/Takeda) and private companies (SARcode Biosciences, ForSight VISION5, Graybug Vision); small molecules, biologics, sustained-release, drug delivery; ocular surface, glaucoma, retinal diseases and collagen-based medical devices..
Listed skills include Biotechnology, Clinical Trials, Drug Development, Clinical Development, and 27 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Suzhou, CN
Eluminex Biosciences is a privately-held clinical-stage biotechnology company focused on both global and regional development and commercialization of innovative therapeutics to fulfill unmet medical needs in the treatment and management of vision-threatening diseases.
Minneapolis, MN, US
DiaMedica Therapeutics is a clinical-stage biopharmaceutical company committed to changing the treatment paradigm for acute ischemic stroke (AIS) and chronic kidney disease (CKD). DiaMedica’s lead candidate DM199 is the first pharmaceutically active recombinant (synthetic) form of the KLK1 protein, an established therapeutic modality for the treatment of.
Palo Alto, CA, US
Development of minimally invasive endovascular treatments for venous disease and complex aortic dissection and thoracic aneurysm repair. Fellowship Program Director.
Graybug is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve.
(Acquired by Allergan for $95M plus milestones) Sustained-delivery of bimatoprost using a novel ocular insert for the treatment of glaucoma/ocular hypertension. Phase 1, 2 development programs and Phase 3 planning. Development of fixed combination (bimatoprost/timolol) ocular insert for glaucoma/ocular hypertension.
Tokyo, JP, JP
Global clinical development lead for Xiidra (lifitegrast ophthalmic solution) for dry eye disease (acquired from SARcode Bioscience). Approved by FDA July 2016.
Brisbane, California, US
(Acquired by Shire for $160M plus future milestones). Development of lifitegrast ophthalmic solution for dry eye disease. IND filing through NDA.
South San Francisco, California, US
Clinical development team leader for ranibizumab (Lucentis), Phase 1b through BLA-filing and FDA approval (June 2006); neovascular age-related macular degeneration(AMD), diabetic macular edema (DME), retinal vein occlusion (RVO). Cardiovascular medicine - clinical lead sBLA TNKase (tenecteplase) approval - acute myocardial infarction, sBLA Activase.
Quick answers generated from the profile data available on this page.
Charles Semba (仙波), Md works for Eluminex Biosciences Limited.
Charles Semba (仙波), Md is listed as Chief Medical Officer and Board Member. Developing global innovative therapeutics for dermal aesthetics and vision-threatening diseases. Look better. See better. at Eluminex Biosciences Limited.
AeroLeads has found 1 work email signal at @sarcode.com for Charles Semba (仙波), Md at Eluminex Biosciences Limited.
AeroLeads has found 11 phone signal(s) with area code 650, 415, 619, 858 for Charles Semba (仙波), Md at Eluminex Biosciences Limited.
Charles Semba (仙波), Md is based in South San Francisco, California, United States while working with Eluminex Biosciences Limited.
Charles Semba (仙波), Md has worked for Eluminex Biosciences Limited, Diamedica Therapeutics Inc., Stanford University School Of Medicine, Graybug Vision, Inc., and Forsight Vision5, Inc..
You can use AeroLeads to view verified contact signals for Charles Semba (仙波), Md at Eluminex Biosciences Limited, including work email, phone, and LinkedIn data when available.
Charles Semba (仙波), Md holds Diagnostic Radiology from Uc San Diego.
Charles Semba (仙波), Md is listed with skills including Biotechnology, Clinical Trials, Drug Development, Clinical Development, Pharmaceutical Industry, Immunology, Biopharmaceuticals, and Medical Devices.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts